CRITICAL THERAPEUTICS,INC.
Critical Therapeutics, Inc., a biopharmaceutical company focused on developing and commercializing innovative products for respiratory and inflammatory diseases.
CRITICAL THERAPEUTICS,INC.
Industry:
Biopharma Biotechnology Clinical Trials Health Care Pharmaceutical Therapeutics
Founded:
2000-01-01
Address:
Lexington, Massachusetts, United States
Country:
United States
Website Url:
http://www.criticaltherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
(781) 402-5700
Total Funding:
66 M USD
Technology used in webpage:
SPF Amazon AWS Global Accelerator
Current Advisors List
Investors List
Advanced Technology Ventures
Advanced Technology Ventures investment in Series B - Critical Therapeutics,Inc.
Oxford Bioscience Partners
Oxford Bioscience Partners investment in Series B - Critical Therapeutics,Inc.
MPM Capital
MPM Capital investment in Series B - Critical Therapeutics,Inc.
HealthCare Ventures
HealthCare Ventures investment in Series B - Critical Therapeutics,Inc.
MedImmune Ventures
MedImmune Ventures investment in Series B - Critical Therapeutics,Inc.
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation investment in Series B - Critical Therapeutics,Inc.
MPM Capital
MPM Capital investment in Series A - Critical Therapeutics,Inc.
HealthCare Ventures
HealthCare Ventures investment in Series A - Critical Therapeutics,Inc.
Official Site Inspections
http://www.criticaltherapeutics.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 13.248.169.48
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Critical Therapeutics,Inc."
www.criticaltherapeutics.com
Www.criticaltherapeutics.comSee details»
Organization | Critical Therapeutics
Organization Overview. First Clinical Trial. 2004 NCT00098358. First Marketed Drug. None First NDA Approval. None Last Known Activity ... Critical Therapeutics/Clinquest Inc Active …See details»
Critical Therapeutics,Inc. - Funding, Financials ... - Crunchbase
Critical Therapeutics, Inc. is a privately held biopharmaceutical company focused on critical care medicine. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... How much …See details»
Critical Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap
Explore Critical Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 6 clinical trials, 5 news, and 2 literature, Drug:Ethyl Pyruvate ...See details»
Critical Therapeutics,Inc. - Crunchbase
Critical Therapeutics, Inc. is a privately held biopharmaceutical company focused on critical care medicine.See details»
History - Chiesi USA
The organizations shared a focus on their people and a desire to address unmet medical needs in the specialty setting. Evolution of Chiesi USA. HIS. October 2008 . Cornerstone BioPharma …See details»
Critical Therapeutics - Products, Competitors, Financials, …
Critical Therapeutics is a biopharmaceutical company is focused on the discovery, development and commercialization of products for respiratory, inflammatory and critical care diseases. Use …See details»
Critical Therapeutics, Inc. Files Controlled Release ... - BioSpace
Aug 1, 2006 About Critical Therapeutics. Critical Therapeutics, Inc. is a biopharmaceutical company focused on critical care medicine. CTI’s mission is the discovery, development and …See details»
Critical Therapeutics Inc. - BioCentury Company Profiles - BCIQ
Critical Therapeutics Inc. - BioCentury Company Profiles for the biopharma industrySee details»
Critical Therapeutics Signs Definitive Agreement to Merge with ...
May 2, 2008 LEXINGTON, Mass. and CARY, N.C. - May 1, 2008 – Critical Therapeutics, Inc. (NASDAQ: CRTX) and Cornerstone BioPharma Holdings, Inc., a privately-held company ...See details»
Critical Therapeutics gets US okay on asthma drug | Reuters
May 31, 2007 Critical Therapeutics Inc. <CRTX.O> said its twice-daily extended-release asthma drug got U.S. marketing approval, and the company's shares rose more than 50 percent in pre …See details»
Cornerstone BioPharma Announces Completion of Merger with …
Nov 3, 2008 Immediately prior to the consummation of the merger, Critical Therapeutics effected a 10-to-1 reverse stock split of its common stock. As a result of the reverse stock split and the …See details»
Critical Therapeutics proposes $103 mln IPO - MarketWatch
WASHINGTON (CBS.MW) -- Critical Therapeutics has proposed to sell stock in a $103 million initial public offering, according to registration papers filed with the Securities and Exchange …See details»
Critical Therapeutics launches Phase I clinic | EurekAlert!
Critical Therapeutics, Inc. of Cambridge has launched a Phase I human study to evaluate the safety and tolerability of the company's anti-inflammatory compound CTI-01. To assess the …See details»
Working at Critical Therapeutics - Glassdoor
Glassdoor gives you an inside look at what it's like to work at Critical Therapeutics, including salaries, reviews, office photos, and more. This is the Critical Therapeutics company profile. …See details»
Critical Drugs for Critical Care: Protecting the US ... - PubMed
Affiliation 1 Mariana P. Socal and Joshua M. Sharfstein are with the Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. Jeremy …See details»
Critical Therapeutics,Inc. - Contacts, Employees, Board Members ...
Critical Therapeutics,Inc. has 1 board member or advisor, Christopher K. Mirabelli. Christopher K. Mirabelli Board Member Unlock even more features with Crunchbase ProSee details»
Cara Therapeutics and Tvardi Therapeutics Announce Entry
1 day ago Management and Organization. Following the Merger, the combined company will be headquartered in Houston, Texas, and will be led by Tvardi’s CEO, Imran Alibhai, Ph.D., and …See details»
Cara Therapeutics and Tvardi Therapeutics Announce Entry into …
1 day ago Management and Organization. Following the Merger, the combined company will be headquartered in Houston, Texas, and will be led by Tvardi’s CEO, Imran Alibhai, Ph.D., and …See details»
ClinicalTrials.gov
Glossary. Study record managers: refer to the Data Element Definitions if submitting registration or results information.. Search for termsSee details»